Tscan Therapeutics Inc (TCRX)
$5.71 -$0.23 (-3.93%) 11:17 PM 07/06/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$301.85M -
Day's Range
$5.51 - $5.86 -
Volume
878,678 -
52 Week Low / High
$1.93 - $9.69 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
TCRX's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 4
- Strong Buy
- 4
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $10.75
- Target Price
Company News
-
TScan Therapeutics Named Top Place to Work by The Boston Globe for Two Consecutive Years — Nov 30th, 2023
WALTHAM, Mass., Nov. 30, 2023 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced it has ...
Similar Stocks
No similar stocks found.
|
$